Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Immune Therapeutics, Inc. (IMUN)
|
|
Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Short-term debt | 3.1 | 2.8 | 5.5 | | 4.8 | 4.2 | 2.8 | 0.2 |
Long-term debt | | | | | | | | 0.8 |
Total debt | 3.1 | 2.8 | 5.5 | | 4.8 | 4.2 | 2.8 | 1.0 |
Net debt | 2.6 | 2.8 | 5.5 | | 4.8 | 4.2 | 2.8 | 0.8 |
|
Debt to EBITDA | 0.8 | | | | | | | |
Net debt to EBITDA | 0.7 | | | | | | | |
|
EBITDA interest coverage | 18.0 | | | | | | | |
EBIT interest coverage | 18.0 | | | | | | | |
|